Jost W H, Schimrigk K
Neurologische Klinik, Universität des Saarlandes, Homburg/Saar, Federal Republic of Germany.
Wien Klin Wochenschr. 1994;106(21):673-6.
Disorders of autonomic regulation are common in patients with Parkinson's disease (PD). Patients most frequently complain of dysphagia and therapy resistant constipation, as far as the gastrointestinal tract is concerned. These symptoms have to be attributed to a neuronal degeneration. In a pilot study we therefore investigated the effect of stimulation of the myenteric plexus by cisapride. 11 women and 13 men were examined, the average age was 67.3 years, the Webster rating 17 points. In 2 out of 24 patients, colonic transit was prolonged up to the limit, both with and without therapy. The other 22 patients showed an acceleration in transit on response to cisapride. On average the colonic transit of 130 hours was reduced to 79 hours. This objective improvement was associated with a subjective improvement. Central side effects or a worsening of Parkinsonian symptoms were not found. We conclude that cisapride is effective in the treatment of constipation in idiopathic PD.
自主神经调节紊乱在帕金森病(PD)患者中很常见。就胃肠道而言,患者最常抱怨吞咽困难和难治性便秘。这些症状必须归因于神经元变性。因此,在一项初步研究中,我们研究了西沙必利刺激肌间神经丛的效果。共检查了11名女性和13名男性,平均年龄为67.3岁,韦氏评分17分。24名患者中有2名,无论是否接受治疗,结肠运输时间均延长至极限。其他22名患者在服用西沙必利后结肠运输加快。平均而言,结肠运输时间从130小时缩短至79小时。这种客观改善与主观改善相关。未发现中枢性副作用或帕金森症状恶化。我们得出结论,西沙必利对特发性帕金森病便秘的治疗有效。